Company profile for Sen-Jam Pharmaceutical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sen-Jam Pharmaceutical is on a mission to help people live side-effect free. We develop consumer healthcare products that help people stay strong by mitigating common side effects from medicines and everyday living. Sen-Jam's Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monog...
Sen-Jam Pharmaceutical is on a mission to help people live side-effect free. We develop consumer healthcare products that help people stay strong by mitigating common side effects from medicines and everyday living. Sen-Jam's Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. Sen-Jam innovates to eliminate many painful side effects. Whether they come from medicine or everyday living. Our product line is based on Opioid Free Pain Relief with GI Protection for Extended Use.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
223 Wall Street #130 • Huntington, NY 11743
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-secures-major-strategic-partnership-with-task-clinical-to-fund-two-thirds-of-phase-3-trial-for-sjp-001-302639230.html

PR NEWSWIRE
11 Dec 2025

https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-advances-addiction-therapeutic-platform-with-breakthrough-preclinical-results-leading-to-patent-for-stimulant-withdrawal-302586919.html

PR NEWSWIRE
17 Oct 2025

https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-and-kvk-tech-complete-final-cmc-deliverables-for-sjp-002c-paving-the-way-for-late-stage-clinical-development-302567843.html

PR NEWSWIRE
26 Sep 2025

https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-positions-sjp-002c-as-a-transformative-complement-to-glp-1-therapies-and-a-standalone-solution-for-mash-302527772.html

PR NEWSWIRE
12 Aug 2025

https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-advances-first-in-class-fda-hangover-prevention-therapy-sjp-001-to-phase-2-trials-in-canada-302513664.html

PR NEWSWIRE
25 Jul 2025

https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-launches-healthspan-catalyst-fund-two-paths-tax-deductible-giving-via-catacap-or-equity-crowdfunding-on-wefunder-302510794.html

PR NEWSWIRE
22 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty